Bicalutamide Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 50 mg , 150 mg
Reference Brands: Casodex®(US & EU)
Category:
Oncology Cancer Care
Bicalutamide is an oral anti-androgen used in prostate cancer treatment, available as 50 mg and 150 mg tablets in the US and EU.
Bicalutamide is available in Tablets
and strengths such as 50 mg , 150 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Bicalutamide is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Bicalutamide can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Bicalutamide Tablets, available in 50 mg and 150 mg strengths, are widely used in the treatment of prostate cancer in both the US and EU. As a non-steroidal anti-androgen, Bicalutamide inhibits androgen receptors to block testosterone-driven cancer growth, making it an essential part of combination therapy with LHRH analogs or as monotherapy. Marketed under brands like Casodex®, it is a globally trusted oncology drug. Bicalutamide is manufactured under GMP conditions, ideal for B2B pharmaceutical sourcing, contract manufacturing, and global distribution. Its high stability and oral dosage form make it a preferred API for regulated markets.
? Short Description
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing